Velso 100mg/400mg Tablets (28s)

Product Overview

Velso 100mg 400mg tablets by Genix are a powerful combination medication used to treat chronic hepatitis C virus infection in adults. This medication contains the active ingredients Sofosbuvir and Velpatasvir, which work together to inhibit the replication of the hepatitis C virus in the body.

Key Benefits

Effective treatment for chronic hepatitis C virus infection

- Combination of two potent antiviral medications

- High success rates in curing hepatitis C

- Convenient once-daily dosing

How It Works

Sofosbuvir and Velpatasvir work by targeting different steps in the hepatitis C virus life cycle. Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor, while Velpatasvir is a NS5A replication complex inhibitor. Together, they work synergistically to prevent the virus from replicating and spreading in the body, ultimately leading to its elimination.

Storage Instructions

Store Velso tablets at room temperature away from moisture and heat.

- Keep the medication out of reach of children and pets.

- Do not use the tablets if the packaging is torn or shows signs of tampering.

Precautions

Take Velso tablets exactly as prescribed by your healthcare provider.

- The usual recommended dose is one tablet taken orally once daily with or without food.

- Swallow the tablet whole with a glass of water.

- Do not crush, chew, or break the tablet.

Inform your doctor about any other medications you are taking before starting Velso tablets.

- It is important to complete the full course of treatment as prescribed to achieve the best results.

- Consult your healthcare provider if you experience any severe side effects or allergic reactions.

Manufacturer Information

Velso 100mg 400mg tablets are manufactured by Genix Pharmaceuticals, a reputable pharmaceutical company known for producing high-quality medications for various medical conditions. Genix is committed to innovation and excellence in the healthcare industry, ensuring the safety and efficacy of their products.